Navigation Links
Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico
Date:10/20/2009

novative manufacturing solution. We appreciate having the opportunity and support to demonstrate the H1N1 vaccine's safety, immunogenicity and efficacy in Mexico and thereby help with ongoing pandemic response efforts. Similar to our previous announcements regarding our ongoing work in the countries of India and Spain, where we plan to establish in-border production, our planned clinical work in Mexico, if successful, could lead to rapid availability of the vaccine and advance Novavax's regional strategy to assist countries around the globe with such critical needs."

Virus-like particles (VLPs) mimic the external structure of viruses but lack the live genetic material that causes viral replication and infection. VLPs can be designed quickly to match individual viral strains and be produced efficiently using portable cell-culture technology. Novavax's VLP-based vaccine candidates are produced significantly more quickly than egg-based vaccines by using proprietary, portable, recombinant cell-culture technology.

The company will hold an investor conference call to discuss this clinical study at 9:00 a.m. Eastern Time on Tuesday, October 20, 2009. The call will be hosted by Novavax President and Chief Executive Officer Dr. Rahul Singhvi and other members of the company's senior management team. A question and answer session will follow. The dial-in number for the conference call is 1 (866) 206-5917 (International: 1 (703) 639-1106). A live audio webcast of the conference call will be available at www.novavax.com under Investors/Events. Please connect to this website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the webcast.

A replay of the webcast will be available on the website for 90 days after the call and a replay of the conference call will also be available by telephone beginning October 20, 2009 at
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone
2. Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial
3. Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
4. Novavax Presents Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program at World Health Organization Conference
5. Novavax Announces Top Line Results of Phase IIa Clinical Trial for Its Seasonal Influenza VLP (Trivalent) Vaccine Candidate
6. Novavax Announces Preclinical Data for Respiratory Syncytial Virus Vaccine Candidate
7. NOVAVAX Featured at Clinton Global Initiative 2008 Annual Meeting
8. NOVAVAX CEO to Present at 2008 UBS Global Life Sciences Conference
9. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
10. Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008
11. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... , Nov. 28, 2014 According to MedlinePlus, ... the course of their lifetime. For many, these pains are ... that is caused by a variety of factors. For those ... may be the best option. While there are a variety ... performed by Seyed M. Rezaian , M.D., Ph.D., F.R.C.S., ...
(Date:11/28/2014)... LAVAL, QC , Nov. 28, 2014 /CNW Telbec/ ... to announce the appointment of Mrs. Dominique Boudreau ... among its management team. Mrs. Dominique Boudreau ... January 2013 and occupied similar duties for more than ... the Ergioresearch Ltd in January 2013.  Mrs. Boudreau replaces ...
(Date:11/28/2014)... 2014  (Booth #7309, North Hall) — Dicom ... product, DCMSYS Interface WebBridge, at the 100th annual RSNA ... Place, Chicago, Illinois . ... Designed for medical facilities of any size, WebBridge allows ... any non-standard data (e.g. JPEG, TFF, PDF, TXT, etc.) ...
Breaking Medicine Technology:4 Advantages of Laser Back Surgery When Fixing a Herniated Disk 2Ergoresearch announces the appointment of its new Vice Président Finance 2Ergoresearch announces the appointment of its new Vice Président Finance 3Dicom Systems Announces WebBridge Interface at RSNA 2014 2
... AHMEDABAD, India , June 21, 2010 ... healthcare companies has,received Phase I clinical trial permission from the DCGI for ... Centre using a,unique platform technology, ZYOG1 is a novel, oral, anti-diabetic molecule. ... ...
... Ontario , June 18 CardioGenics Holdings Inc. ... Point-Of-Care (POC) analyzer and products for the immunoassay segment of ... filed a Certificate of Change with the Secretary of ... the Company,s authorized and outstanding common stock on a ten ...
Cached Medicine Technology:Zydus' Novel Orally Administered GLP-1 Agonist - 'ZYOG1' to treat Diabetes and Obesity Enters Phase I Clinical Trial 2Zydus' Novel Orally Administered GLP-1 Agonist - 'ZYOG1' to treat Diabetes and Obesity Enters Phase I Clinical Trial 3CardioGenics Announces Reverse Stock Split 2CardioGenics Announces Reverse Stock Split 3
(Date:11/28/2014)... 29, 2014 Somax Performance Institute ... measuring and improving sports performance, is pleased to ... surpassed 3,000,00 views. The Institute, which works with ... improves performance far beyond conventional coaching and training ... Microfiber Reduction. , Many viewers have praised the ...
(Date:11/28/2014)... iFitDress.com is a renowned women’s dress company. ... special occasion gowns for the global clients. Recently, iFitDress.com ... in its online store. The new products are now ... According to the sales manager of the company, the ... popular in the international market. , “We are ...
(Date:11/28/2014)... 2014 The report “Poxvirus Infections ... the therapeutic development for Poxvirus Infections, complete with ... drug target, mechanism of action (MoA), route of ... updates, and featured news and press releases. It ... development for Poxvirus Infections and special features on ...
(Date:11/28/2014)... Recently, SWAccessControl.com, a renowned smartware manufacturer, has announced its ... high end products are offered at discounted rates, up ... from today to Dec 16, 2014. , The company’s ... promotion. We are proud of our new access control ... about our hottest items, we have listed some of ...
(Date:11/28/2014)... The clinic is known for ... Neuromuscular Stabilization, Extracorporeal Shock Wave Therapy, computer assisted ... upgraded facilities in 2011, the clinic unveiled their ... Lev Kalika has launched the most advanced and ... the country. , The new lab allows Dr. ...
Breaking Medicine News(10 mins):Health News:Somax Sports Motion Analysis Videos Surpass 3,000,000 Views 2Health News:Somax Sports Motion Analysis Videos Surpass 3,000,000 Views 3Health News:Discounted Teal Cocktail Dresses From Famous Dress Supplier iFitDress.com 2Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 2Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 3Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 4Health News:New Access Control Systems Now Offered At Low Prices By Smartware Manufacturer SWAccessControl.com 2Health News:New York Dynamic Neuromuscular Rehabilitation Opens Nation's Most Advanced Movement Performance and Injury Prevention Lab 2Health News:New York Dynamic Neuromuscular Rehabilitation Opens Nation's Most Advanced Movement Performance and Injury Prevention Lab 3
... MONDAY, Feb. 21 (HealthDay News) -- An estimated 21 percent ... of hearing loss, and the number rises to 90 percent ... Yet much of that hearing loss may be preventable, the ... loss include working in a noisy environment, having a parent ...
... This release is available in French . ... hormone in your spit could reveal if you,re on the ... Lupien and Robert-Paul Juster of the Centre for Studies on ... Montreal. In addition to professional and personal suffering, burnout puts ...
... , MONDAY, Feb. 21 (HealthDay News) -- Educating ... helps increase rates of skin self-examination and follow-up with ... States, an estimated 100,000 living kidney transplant recipients are ... tumors occurring in the skin that can spread to ...
... , MONDAY, Feb. 21 (HealthDay News) -- Hypertension and high ... abilities in middle age, a new study finds. Researchers ... 1,300 British women with an average age of 55 who ... civil servants. Three times over the course of a ...
... HealthDay Reporter , SUNDAY, Feb. 20 (HealthDay News) ... developing Parkinson,s disease later, new research suggests. But, ... a cause-and-effect relationship and further investigation is warranted. ... investigator at the Division of Research at Kaiser Permanente ...
... infected with the antibiotic-resistant bacterium MRSA (methicillin-resistant Staphylococcus ... may be more important than the choice of ... study. The work is published in the March issue ... to compare the efficacy of two antibiotics commonly used ...
Cached Medicine News:Health News:Hearing Loss Common Among Middle-Aged Adults: Study 2Health News:Hearing Loss Common Among Middle-Aged Adults: Study 3Health News:Simple spit and blood tests might detect burnout before it happens 2Health News:Simple spit and blood tests might detect burnout before it happens 3Health News:Education Might Help Kidney Recipients Spot Skin Cancer 2Health News:High Cholesterol, Hypertension May Harm Memory in Middle Age 2Health News:High Cholesterol, Hypertension May Harm Memory in Middle Age 3Health News:Can Prescription Amphetamine Use Raise Parkinson's Risk? 2Health News:Can Prescription Amphetamine Use Raise Parkinson's Risk? 3Health News:Careful cleaning of children's skin wounds key to healing, regardless of antibiotic choice 2
... An enzyme linked ... the detection and semiquantitation ... (GBM) antibodies in human ... GBM antibodies can be ...
An indirect immunofluorescence (IFA) antibody test for the detection and semiquantitation of anti-glomerular basement membrane (GBM) antibodies in human serum. Slide Detail: 6-well Monkey Kidney Subs...
Rheumatoid factor screening...
An enzyme linked immunosorbant assay (ELISA) for the detection and quantitation of Rheumatoid Factor (RF) IgA isotype in human serum....
Medicine Products: